Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA) is a global health concern. Many antibiotics are no longer effective at treating MRSA, which causes an increase in adverse patient outcomes. This has led to calls for new antibiotics and treatment strategies to combat the spread of MRSA and multidr...
| প্রধান লেখক: | |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | English |
| প্রকাশিত: |
Vietnam Ministry of Science and Technology
2022-12-01
|
| মালা: | Vietnam Journal of Science, Technology and Engineering |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://vietnamscience.vjst.vn/index.php/vjste/article/view/1087 |
| _version_ | 1828047961003655168 |
|---|---|
| author | Emerson Joseph Addison |
| author_facet | Emerson Joseph Addison |
| author_sort | Emerson Joseph Addison |
| collection | DOAJ |
| description |
Methicillin-resistant Staphylococcus aureus (MRSA) is a global health concern. Many antibiotics are no longer effective at treating MRSA, which causes an increase in adverse patient outcomes. This has led to calls for new antibiotics and treatment strategies to combat the spread of MRSA and multidrug resistance (MDR). The antimicrobial secondary metabolites found in plants are a promising source for new antibiotics and treatment strategies. Cannabis sativa L. is especially promising, as it produces dozens of antimicrobial secondary metabolites that are active against Staphylococcus aureus (S. aureus) and MRSA strains. In addition to its antimicrobial properties against S. aureus and MRSA, cannabis has many other desirable properties for potential antibiotics. Cannabis secondary metabolites are active against a wide range of microorganisms, are generally safe, target multiple bacterial processes and structures, have antimicrobial synergies, have a low potential for resistance development, can be produced inexpensively and combined with existing antibiotics to further reduce costs, and contain secondary metabolites capable of penetrating a variety of in vivo environments. These characteristics make cannabis a potential resource against MRSA and MDR bacteria.
|
| first_indexed | 2024-04-10T18:50:00Z |
| format | Article |
| id | doaj.art-12dd255eade0429e94a518cca8bf418d |
| institution | Directory Open Access Journal |
| issn | 2525-2461 2615-9937 |
| language | English |
| last_indexed | 2024-04-10T18:50:00Z |
| publishDate | 2022-12-01 |
| publisher | Vietnam Ministry of Science and Technology |
| record_format | Article |
| series | Vietnam Journal of Science, Technology and Engineering |
| spelling | doaj.art-12dd255eade0429e94a518cca8bf418d2023-02-01T08:10:36ZengVietnam Ministry of Science and TechnologyVietnam Journal of Science, Technology and Engineering2525-24612615-99372022-12-0164410.31276/VJSTE.64(4).70-78Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureusEmerson Joseph Addison Methicillin-resistant Staphylococcus aureus (MRSA) is a global health concern. Many antibiotics are no longer effective at treating MRSA, which causes an increase in adverse patient outcomes. This has led to calls for new antibiotics and treatment strategies to combat the spread of MRSA and multidrug resistance (MDR). The antimicrobial secondary metabolites found in plants are a promising source for new antibiotics and treatment strategies. Cannabis sativa L. is especially promising, as it produces dozens of antimicrobial secondary metabolites that are active against Staphylococcus aureus (S. aureus) and MRSA strains. In addition to its antimicrobial properties against S. aureus and MRSA, cannabis has many other desirable properties for potential antibiotics. Cannabis secondary metabolites are active against a wide range of microorganisms, are generally safe, target multiple bacterial processes and structures, have antimicrobial synergies, have a low potential for resistance development, can be produced inexpensively and combined with existing antibiotics to further reduce costs, and contain secondary metabolites capable of penetrating a variety of in vivo environments. These characteristics make cannabis a potential resource against MRSA and MDR bacteria. https://vietnamscience.vjst.vn/index.php/vjste/article/view/1087antimicrobial secondary metabolitescannabinoidscannabiscannabis sativacombination therapymethicillinresistant |
| spellingShingle | Emerson Joseph Addison Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus Vietnam Journal of Science, Technology and Engineering antimicrobial secondary metabolites cannabinoids cannabis cannabis sativa combination therapy methicillinresistant |
| title | Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus |
| title_full | Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus |
| title_fullStr | Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus |
| title_full_unstemmed | Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus |
| title_short | Review Cannabis: A new strategy against methicillin-resistant Staphylococcus aureus |
| title_sort | review cannabis a new strategy against methicillin resistant staphylococcus aureus |
| topic | antimicrobial secondary metabolites cannabinoids cannabis cannabis sativa combination therapy methicillinresistant |
| url | https://vietnamscience.vjst.vn/index.php/vjste/article/view/1087 |
| work_keys_str_mv | AT emersonjosephaddison reviewcannabisanewstrategyagainstmethicillinresistantstaphylococcusaureus |